Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in invasive bladder cancer in clinical practice.

被引：0
|
作者：
Mehler, Shoshana
Guilbeau, Seth
Somer, Shmuel
Reed, Kevin
Greene, Heather
Vaena, Daniel A.
Grothey, Axel
Somer, Brad
机构：
[1] West Canc Ctr, Memphis, TN USA
[2] Univ Tennessee, Med Ctr, Knoxville, TN USA
[3] West Canc Ctr & Res Inst, Germantown, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
542
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Reference Standards for the Determination of Limit of Blank (LoB) and Limit of Detection (LoD) in Tumor-Informed, ctDNA Minimal Residual Disease (MRD) Assays
    Raymond, C.
    Fransen, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S135 - S135
  • [22] Personalized, tumor-informed, circulating tumor DNA assay for detecting minimal residual disease in non-small cell lung cancer patients receiving curative treatments
    Oh, Youjin
    Yoon, Sung Mi
    Lee, Jeeyeon
    Park, Joo Hee
    Lee, Soowon
    Hong, Timothy
    Chung, Liam Il-young
    Sudhaman, Sumedha
    Riddell, Timothy
    Palsuledesai, Charuta C.
    Krainock, Michael
    Liu, Minetta C.
    Chae, Young Kwang
    THORACIC CANCER, 2024, 15 (13) : 1095 - 1102
  • [23] Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.
    Wang, Xiuchao
    Wang, Hongwei
    Chen, Xinyun
    Liu, Yuxiao
    Zhao, Tiansuo
    Gao, Song
    Wang, Jian
    Ma, Weidong
    Gao, Chuntao
    Hao, Jihui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 744 - 744
  • [24] Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer
    Paspalj, Valentina
    Grimm, Christoph
    Postl, Magdalena
    Tauber, Christina Viktoria
    Segui, Nuria
    Brueffer, Christian
    Alcaide, Miguel
    Oton, Lucia
    Chen, Yilun
    Saal, Lao H.
    Hofstetter, Gerda
    Muellauer, Leonhard
    Kessler, Mirjana
    Trillsch, Fabian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay
    Parikh, A.
    van Seventer, E.
    Boland, G.
    Siravegna, G.
    Hartwig, A.
    Jaimovich, A.
    Raymond, V. M.
    Talasaz, A.
    Corcoran, R. B.
    ANNALS OF ONCOLOGY, 2020, 31 : S419 - S419
  • [26] Multiomic, plasma-only circulating tumor DNA (ctDNA) assay identifies breast cancer patients with minimal residual disease (MRD) and predicts distant recurrence
    Janni, Wolfgang
    Huober, Jens
    Braun, Tatjana
    Mueller, Volkmar
    Fink, Angelina
    de Gregorio, Amelie
    Rack, Brigitte
    Friedl, Thomas W.
    Wiesmueller, Lisa
    Pantel, Klaus
    Rich, Thereasa
    Parsana, Princy
    Zotenko, Elena
    Zhang, Shile
    Huesmann, Sophia
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
    Chakrabarti, Sakti
    Kasi, Anup Kumar
    Parikh, Aparna R.
    Mahipal, Amit
    CANCERS, 2022, 14 (13)
  • [28] Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma
    Ueberroth, Benjamin E.
    Jones, Jeremy C.
    Bekaii-Saab, Tanios S.
    PANCREATOLOGY, 2022, 22 (06) : 741 - 748
  • [29] Exploration of Factors Affecting the Performance of MRD Tumor-Informed Assay in Chinese Lung Cancer Patients
    Lin, G.
    Wang, A.
    Li, F.
    Gu, P.
    Zhou, H.
    Yao, J.
    Wang, M.
    Liu, W.
    Zheng, X.
    Zheng, X.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S578 - S578
  • [30] INTERCEPT Program of circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) in colorectal cancer (CRC): Results from a prospective clinical cohort.
    Maddalena, Giulia
    Pellatt, Andrew Jared
    Eluri, Madhulika
    Parseghian, Christine Megerdichian
    Aziz, Kathryn
    Alfaro, Kristin
    Kell, Robert J.
    Bent, Alisha Heather
    Huey, Ryan W.
    Uppal, Abhineet
    Konishi, Tsuyoshi
    Overman, Michael J.
    Morelli, Maria Pia
    Willis, Jason
    Shen, John Paul Y. C.
    Raghav, Kanwal Pratap Singh
    Newhook, Timothy E.
    Morris, Van K.
    Dasari, Arvind
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 27 - 27
12345